drugset
drugset / Trial / NCT04568837

Steroids After Spine Fusion Surgery

NCT04568837 ↗

Phase 4 Not yet recruiting 420 enrolled Oregon Health and Science University
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial studies how well low-dose postoperative corticosteroids (FDA approved) affect patient outcomes (patient reported outcomes, pain medication use, length of stay, major complications, and time to first bowel movement) after thoracic and/or lumbar spine fusion surgery.

Timeline

Start
2025-03-01
Primary completion
2026-10-06
Completion
2026-10-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 1 ml Intravenous
Subject Prednisone Other / unclassified 20 mg Oral

Indications

No indication recorded.